Robert Gluckman, MD, MACP, from Providence Health Plan, spoke about how medicine and pharmacist interaction can be cost-effective.
In an interview regarding the Newport Beach Institute for Value Based Medicine® conference, Robert Gluckman, MD, MACP, chief medical officer, Providence Health Plan, talked about what he wanted the key takeaways to be as well as how Providence Health Plan reduces cost in medicine and pharmacist interactions.
Transcript
What do you think the role of Providence Health Plan is in making medicine and pharmacist interactions cost-effective?
So one of the things we've done at Providence Health Plan has actually helped support providers, especially primary care practices, with embedded pharmacists. So that can help facilitate ensuring that providers are prescribing effective care, but also informing those providers around payer policy, so that we can reduce the abrasion around denials and make sure that patients can get the care they need as quickly as possible.
What do you want attendees to take away from the IVBM?
I think the biggest thing I wanted people to take away is there is so much opportunity and benefit for the new advances that pharmacy is bringing to the market. And at the same time, we also have this incredible responsibility on how to make things affordable for people. It's going to take a lot of creativity to think about how we're able to bring some of these really important advances but do it in a way that's responsible for society.
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen
Designing Care for the Underserved Creates Higher-Value Health Solutions
January 12th 2025In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.
Read More